Foreign-Body Reaction: Clinical Trials

3 trials for Foreign-Body Reaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Not yet recruiting 1
Phase 11Completed 1
Phase 31Not yet recruiting 1

Follow Foreign-Body Reaction: new trials by email Literature Review of Foreign-Body Reaction trials Research Report on Foreign-Body Reaction

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The GranStone Trial
empagliflozin (Jardiance) 25 mg, Losartan 100 mg - Paraffinoma, Granuloma, Foreign-Body
Phase 2 / Phase 3Not yet recruitingMartin Blomberg Jensen1002026-09-012026-09-18
IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.
Cartilage repair surgery - Foreign-Body Reaction, Inflammation
Phase 1 / Phase 2CompletedUMC Utrecht352013-03-012019-01-02
Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements
Placebo, Apatone®B - Edematous, Synovitis
Phase 2CompletedIC-MedTech Corporation572010-10-012018-01-31

Narrower conditions

Edema (1)  ·  Granuloma, Foreign-Body (1)  ·  Hypercalcemia (1)  ·  Inflammation (1)  ·  Nephrocalcinosis (1)  ·  Nephrolithiasis (1)  ·  Osteolysis (1)  ·  Synovitis (1)  ·  Tooth, Impacted (1)

Broader conditions

Foreign Bodies (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Wounds and Injuries (3)  ·  Bone Diseases (1)  ·  Bone Resorption (1)  ·  Calcinosis (1)  ·  Calcium Metabolism Disorders (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Granuloma (1)  ·  Inflammation (1)  ·  Joint Diseases (1)  ·  Kidney Diseases (1)

Interventions

Losartan (1)  ·  empagliflozin (1)

Sponsors

IC-MedTech Corporation (1)  ·  Martin Blomberg Jensen (1)  ·  UMC Utrecht (1)

Countries

Denmark (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Daniel B.F. Saris, MD, PhD (1)  ·  Mark W Kovacik, BS (1)  ·  Martin B Jensen, Professor (1)  ·  Thomas F Bear, MD (1)  ·  Tommy S. de Windt, MD (1)